Tech Company Financing Transactions

Cold Genesys Funding Round

Cold Genesys, based in ?Irvine, secured $10 million from Ally Bridge Group, WI Harper and Song Hong Fang.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

Ally Bridge Group (Lead Investor) (Arthur Kuan)

WI Harper (Lead Investor) (Peter Liu)

Song Hong Fang

Whitesun Healthcare Ventures

Proceeds Purpose
The insider-initiated $10 million Series B financing will advance Cold Genesys' investigational oncolytic immunotherapy CG0070 in a pivotal study (BOND II) that is currently enrolling 122 patients with high-risk non-muscle invasive bladder cancer (NMIBC) who have failed first-line BCG therapy. In addition, proceeds from this financing will be used to develop the combination of CG0070 with immune checkpoint modulators in multiple Phase I/II studies for different solid tumor indications.

Company Information

Company Status
Private & Independent
Mailing Address
400 Spectrum Center Dr. 2040
?Irvine, CA 92618
Email Address
Cold Genesys, Inc., a clinical-stage biopharmaceutical company developing oncolytic immunotherapies for cancer.
Cold Genesys LinkedIn Company Profile
Social Media
Cold Genesys Company Twitter Account
Company News
Cold Genesys News
Cold Genesys on Facebook
Cold Genesys on YouTube

Management Team

Email & Social
Chief Executive Officer
Arthur Kuan
  Arthur Kuan LinkedIn Profile  Arthur Kuan Twitter Account  Arthur Kuan News  Arthur Kuan on Facebook
Chief Scientific Officer
Paola Grandi
  Paola Grandi LinkedIn Profile  Paola Grandi Twitter Account  Paola Grandi News  Paola Grandi on Facebook
Amy Steele
  Amy Steele LinkedIn Profile  Amy Steele Twitter Account  Amy Steele News  Amy Steele on Facebook
VP - Bus. Development
Bing Kung
  Bing Kung LinkedIn Profile  Bing Kung Twitter Account  Bing Kung News  Bing Kung on Facebook
VP - Manufacturing
Bradley Grimm
  Bradley Grimm LinkedIn Profile  Bradley Grimm Twitter Account  Bradley Grimm News  Bradley Grimm on Facebook



Browse more venture capital transactions:

Prev: 8/6/2015: IncludeFitness venture capital transaction
Next: 8/6/2015: Zest Health venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary